Literature DB >> 7712279

Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits.

R Broadbent1, T F Fok, M Dolovich, J Watts, G Coates, B Bowen, H Kirpalani.   

Abstract

AIMS: To investigate the correlation between chest position and the distribution of surfactant in the lungs of surfactant depleted rabbits, to corroborate current guidelines on the intratracheal instillation of exogenous surfactant in newborns.
METHODS: Twelve tracheotomised rabbits, depleted of pulmonary surfactant by saline bronchoalveolar lavage, were given intratracheal 99m Technetium labelled Exosurf in three positions (prone, right side down, and left side down) (n = 4 in each group). They were monitored for 10 minutes using dynamic gamma scintigraphy monitoring. Instillation completed, the lateral lying animals were turned to the opposite side to determine whether redistribution of the surfactant had taken place. The amount of radiolabelled surfactant deposited at the peripheral, central, dorsal and ventral parts of the lungs was then estimated by gamma counting of the lung sections at necropsy.
RESULTS: Both gamma scintigraphy and gamma counting showed similar rates and total amount of surfactant accumulation in both lungs of the prone animals. In the lateral lying animals surfactant accumulated at a significantly faster rate in the dependent lungs: the amount of surfactant deposition was three to 14-fold that in the raised lungs (p = 0.017; nested ANOVA). Changing the chest position immediately after instillation did not redistribute the surfactant. In all three groups of animals there was no significant difference in deposition between the peripheral, central, ventral and dorsal parts of the lungs.
CONCLUSIONS: Pulmonary distribution of intratracheally instilled surfactant is largely determined by gravity, and changing the chest position after instillation does not result in any redistribution of the surfactant. During the instillation of exogenous surfactant to newborn infants, keeping the chest in the horizontal position may therefore result in the most even distribution of the surfactant in the two lungs. Further deposition studies are required to evaluate the validity of the current recommendations on surfactant administration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7712279      PMCID: PMC2528397          DOI: 10.1136/fn.72.2.f84

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  13 in total

1.  Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.

Authors:  T Fujiwara; M Konishi; S Chida; K Okuyama; Y Ogawa; Y Takeuchi; H Nishida; H Kito; M Fujimura; H Nakamura
Journal:  Pediatrics       Date:  1990-11       Impact factor: 7.124

2.  Aerosolized surfactant treatment of preterm lambs.

Authors:  J F Lewis; M Ikegami; A H Jobe; B Tabor
Journal:  J Appl Physiol (1985)       Date:  1991-02

3.  Distribution of surfactant, lung compliance, and aeration of preterm rabbit lungs after surfactant therapy and conventional and high-frequency oscillatory ventilation.

Authors:  G P Heldt; T A Merritt; D Golembeski; N Gilliard; C Bloor; R Spragg
Journal:  Pediatr Res       Date:  1992-03       Impact factor: 3.756

4.  Short-term distribution kinetics of intratracheally administered exogenous lung surfactant.

Authors:  J M Davis; G A Russ; L Metlay; B Dickerson; B S Greenspan
Journal:  Pediatr Res       Date:  1992-05       Impact factor: 3.756

5.  Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome.

Authors:  A Charon; W Taeusch; C Fitzgibbon; G B Smith; S T Treves; D S Phelps
Journal:  Pediatrics       Date:  1989-03       Impact factor: 7.124

6.  Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury.

Authors:  N Gilliard; P M Richman; T A Merritt; R G Spragg
Journal:  Am Rev Respir Dis       Date:  1990-03

7.  Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.

Authors:  R F Soll; R E Hoekstra; J J Fangman; A J Corbet; J M Adams; L S James; K Schulze; W Oh; J D Roberts; J P Dorst
Journal:  Pediatrics       Date:  1990-06       Impact factor: 7.124

8.  Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume.

Authors:  J van der Bleek; F B Plötz; F M van Overbeek; A Heikamp; H Beekhuis; R H Wildevuur; A Okken; S Bambang Oetomo
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

9.  Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome.

Authors:  E M Zola; J H Gunkel; R K Chan; M O Lim; I Knox; B H Feldman; S E Denson; B S Stonestreet; B R Mitchell; M M Wyza
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406

10.  Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique.

Authors:  H Segerer; W van Gelder; F W Angenent; L J van Woerkens; T Curstedt; M Obladen; B Lachmann
Journal:  Pediatr Res       Date:  1993-10       Impact factor: 3.756

View more
  1 in total

1.  Regional respiratory time constants during lung recruitment in high-frequency oscillatory ventilated preterm infants.

Authors:  Martijn Miedema; Frans H de Jongh; Inez Frerichs; Mariëtte B van Veenendaal; Anton H van Kaam
Journal:  Intensive Care Med       Date:  2011-11-29       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.